Insight

Francisco J. Esteva: The clinical validation results of Ataraxis Breast at SABCS24

Francisco J. Esteva/LinkedIn

Dec 13, 2024, 16:50

Francisco J. Esteva: The clinical validation results of Ataraxis Breast at SABCS24

Francisco J. Esteva, Chief of Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared on LinkedIn:

“Very informative poster presentation by Jan Witowski at the 2024 San Antonio Breast Cancer Symposium.

The clinical validation results of Ataraxis Breast–the first AI-native prognostic/predictive test for breast cancer patients are impressive.

Looking forward to continuing our collaboration with Ataraxis AI on the validation and implementation of AI prognostic and predictive models at Northwell Cancer Institute.”

AI Ataraxis Breast Breast Cancer cancer Francisco J. Esteva Jan Witowski Northwell Cancer Institute OncoDaily Oncology SABCS24 San Antonio Breast Cancer Symposium

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage